AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials

LONDON—The Covid-19 vaccine being developed by the University of Oxford and AstraZeneca PLC was found to be as much as

Read more

FDA Authorizes Regeneron’s Covid-19 Antibody Cocktail Drug

Regeneron Pharmaceuticals Inc.’s Covid-19 antibody drug was authorized Saturday by U.S. health regulators, the second cleared this month to treat

Read more

Exclusive: EU could pay over $10 billion for Pfizer and CureVac vaccines – source

BRUSSELS (Reuters) – The European Union could pay more than $10 billion to secure hundreds of millions of doses of

Read more